15.11.2007 14:20:00
|
Amgen Announces ``My Cancer Coach'' Contest Winners at the College Hoops Classic
Amgen (NASDAQ:AMGN) today announced the results of a contest designed
for cancer survivors to honor and thank their "cancer
coach” — the
spouse, family member or friend who played a crucial role in helping
them with the battle through cancer treatment. The contest, supported by
Amgen Oncology, in which applicants nominated their cancer coach by
submitting a short essay, was announced in November of 2006 and is part
of Amgen’s sponsorship of the College Hoops
Classic benefiting Coaches vs. Cancer. Shelly Bailey and JoAn Barnes
have been selected as outstanding examples of Cancer Coaches for the
support and encouragement they have offered to family members fighting
this devastating disease.
Shelly Bailey of Elk Grove, Calif., was nominated by her husband,
William, for her strength and positive attitude which helped him through
his fight with cancer. William writes, "I had
a secret weapon in battlefield chemo called positive attitude, and an
abundant source of it nearby, named Shelly. She taught me that in
surviving cancer, what goes on between the ears has more to say about
quality of life than what happens from the neck down.”
A devoted and benevolent caregiver, JoAn Barnes was nominated by her
daughter whom she helped fight Hodgkin’s
disease. Barnes also aided her own mother through the end-stage of lung
and brain cancer, another daughter who successfully battled breast
cancer as well as her own husband who just recently lost his battle with
advanced metastatic prostate cancer that had metastasized to his bones. "JoAn
Barnes is the constant, selfless caregiver that makes her a wonderful
cancer coach,” Jessica Oswald writes of her
mother. "She has always made us feel better
just by being there and being the wonderful nurturer she is. She never
chose to assist people through the terrible tribulations of cancer, but
somehow it chose her and I am thankful she was there for me when cancer
called.” "Amgen is proud to honor the winners of the ‘My
Cancer Coach’ contest and to recognize the
important role that all cancer coaches play in the lives of cancer
patients,” said Cynthia Schwalm, vice
president and general manager of Amgen Oncology. "An
active support team that is armed with information and resources can
have a lasting emotional impact on family members and friends managing
their illness.”
Ms. Bailey, Ms. Barnes and a guest of each will receive a trip to the
College Hoops Classic Championship Round games benefiting Coaches vs.
Cancer in New York City on November 16th and 17th. The Classic kicks off
the 2007-2008 college basketball season and teams Amgen Oncology with
the National Association of Basketball Coaches (NABC) to raise funds for
the American Cancer Society (ACS). The Coaches vs. Cancer program,
created by the NABC and ACS, has raised more than $25 million to support
cancer patients since its inception in 1993.
Amgen Oncology is supporting the fight against cancer on multiple fronts
including serving as a major sponsor of the College Hoops Classic. Amgen
encourages those undergoing chemotherapy and those who are helping a
family member or friend through it, to learn more about the ChemoCoach™
program, a valuable resource for cancer patients and caregivers. At www.ChemoCoach.com,
visitors can register to receive an educational email series, which is a
free support program that delivers small doses of powerful information
to help cancer patients and their caregivers better manage the
chemotherapy journey. The site also acts as the gateway to additional
resources and information.
About Amgen
Amgen discovers, develops and delivers innovative human therapeutics. A
biotechnology pioneer since 1980, Amgen was one of the first companies
to realize the new science’s promise by
bringing safe and effective medicines from lab, to manufacturing plant,
to patient. Amgen therapeutics have changed the practice of medicine,
helping millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses. With
a deep and broad pipeline of potential new medicines, Amgen remains
committed to advancing science to dramatically improve people’s
lives. To learn more about our pioneering science and our vital
medicines, visit www.amgen.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Amgen Inc.mehr Nachrichten
26.11.24 |
Dow Jones aktuell: Dow Jones letztendlich mit Gewinnen (finanzen.at) | |
26.11.24 |
Handel in New York: NASDAQ 100 schlussendlich mit positivem Vorzeichen (finanzen.at) | |
26.11.24 |
MÄRKTE USA/Börsenrally geht weiter - Amgen bremsen Dow (Dow Jones) | |
26.11.24 |
Amgen-Aktie fällt: Studiendaten zum Abnehmmittel Maritide enttäuschen (dpa-AFX) | |
26.11.24 |
Zuversicht in New York: Dow Jones am Dienstagnachmittag mit Gewinnen (finanzen.at) | |
26.11.24 |
Optimismus in New York: So entwickelt sich der S&P 500 am Nachmittag (finanzen.at) | |
26.11.24 |
Börse New York in Grün: NASDAQ 100 steigt nachmittags (finanzen.at) | |
26.11.24 |
NASDAQ-Handel: NASDAQ Composite notiert am Nachmittag im Plus (finanzen.at) |
Analysen zu Amgen Inc.mehr Analysen
Aktien in diesem Artikel
Amgen Inc. | 267,25 | 0,96% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 060,48 | -0,60% | |
S&P 500 | 5 998,74 | -0,38% | |
NASDAQ 100 | 20 744,49 | -0,85% | |
S&P 100 | 2 883,15 | -0,41% |